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reduced the occurrence of VAs (2.70.48, 2.50.53, 1.70.48 versus 3.30.95)
and ameliorated the shortening of 90% repolarization of action potential durations
(APD90) and the dispersion of APD (APDd) during myocardial ischemia
reperfusion.
Conclusions: Taxol pre-treatment reduces ischemia-related VAs, improved APD90,
preserves normal Cx43 expression and locations during myocardial ischemia. These
ﬁndings provide potential therapeutic targets for ameliorating VAs during IR.
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Objectives: studies show that dipeptidyl peptidase-4 (DPP-4) inhibitors may have an
anti-atherosclerotic effect. Since foam cells are key components of atherosclerotic
plaque, we studied the effect of DPP-4 inhibitors on foam cell formation.
Methods: Foam cell formation was studied by treatment of primary and THP-1
macrophages with oxidized low density lipoprotein (ox-LDL) in the absence or
presence of DPP-4 inhibitors (sitagliptin and NVPDPP728). The expression of
scavenger receptors (SR) SRA, CD36 and LOX-1 was measured, and their role in
foam cell formation in the presence of DPP-4 inhibitors was examined by their over-
expression. In additional studies, role of protein kinase (PK) C and A in the effect of
DPP-4 inhibitors was examined.
Results: Foam cell formation was markedly reduced by both DPP-4 inhibitors, as was
the expression of CD36 and LOX-1 (CD36>>LOX-1), but not SRA. Simultaneously,
there was a reduction in phosphorylated-PKC, but not PKA, content. Recovery of
phosphorylated-PKC following treatment of cells with PMA negated the effect of
DPP-4 inhibitors on foam cell formation. Further, over-expression of CD36 or LOX-1
blocked the effect of DPP-4 inhibitors on foam cell formation.
Conclusions: DPP-4 inhibitor exerts a potent inhibitory effect on foam cell formation
from human macrophage cell line in response to ox-LDL. This effect is primarily
mediated by decrease in the expression of two different SRs on monocytes/macro-
phages CD36 and LOX-1. This results in a decrease in ox-LDL internalization. DPP-4
inhibitors also exert a potent inhibitor effect on PKC activation, perhaps mediated by
membrane-bound DPP-4, which plays a critical role in foam cell formation, inﬂam-
mation and atherogenesis.
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Objectives: To investigate the association between suppressor of cytokine signaling 3
(SOCS3) genetic polymorphisms and insulin resistance (IR) inXinjiangUygur population.
Methods: In this cross-sectional study on the metabolic diseases (e.g. obesity) among
Uygur Chinese in Hetian, Xinjiang China,1292 Uygur individuals were enrolled. The
sample size for IR subjects [homeostasis model assessment for insulin resistance
(HOMA-IR) 2.96] was 323, whereas that for non-IR controls was 969 (HOMA-
IR<2.96). Representative variations were selected according to gene database and
genotyping using the TaqMan polymerase chain reaction method in 1292 Uygur in-
dividuals. A relatively isolated general population in a relatively homogeneous
environment and a case-control study was conducted to test the association between
the genetic variations of SOCS3 gene and insulin resistance.
Results: There was signiﬁcant difference of genotype distribution of rs4969168
between insulin resistance and control groups in the male population (P¼0.027).
Although the insulin resistance related quantitative phenotypes have no signiﬁcantly
difference in individuals with GG AG and AA genotypes of rs4969168 in total, male
and female population (P>0.05) the mean of body mass index and the median of
fasting insulin increased in individuals with GG AG AA genotypes of rs4969168 in
male population. But not in total and female population. Haplotype 2 (rs12953258C-
rs4969168A-rs9914220C) was signiﬁcantly associated with a higher prevalence of IR
in male population (P¼0.023). The logistic regression analysis showed that AG ge-
notype of rs4969168 variation might be a protective factor for insulin resistance in
male (OR¼0.564, 95% conﬁdence interval 0.344-0.925. P¼0.023).
Conclusions: The present study suggests that the rs4969168 polymorphism in SOCS3
gene may be associated with insulin resistance in Xinjiang Uygur men.
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Medical University, Chongqing, People’s Republic of ChinaJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BObjectives: The aim of this study was to investigate the effects of soluble complement
receptor 1 (sCR1) on rat models of myocardial I/R, explore its potential mechanisms
of cardioprotection.
Methods: Myocardial ischemia-reperfusion model was built, randomly assigned to
sham operation group (SOG) and ischemia reperfusion group (IRG) and sCR1 pre-
treatment group (CPG). Observation on myocardial infarct size and microstructure of
each group, using RT-PCR and Elisa to detect expression of LC3-II and Beclin1
mRNA and protein.
Results: Compared with IRG, myocardial infarct size and microstructure damage are
reduced in CPG. The mRNA and protein of Beclin1 and LC3-II were detected in each
group of Myocardial, while in CPG increased than IRG.
Conclusions: sCR1 could protect myocardial ischemia-reperfusion injury, may be
associated with fading excessive autophagy in myocardiac.
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Objectives: To investigate the effects of salvianolic acid on the proliferation, adhesion
and nitric oxide (NO) secretion activity of endothelial progenitor cells (EPCs) cultured
in vitro.
Methods: The mononuclear cells (MNCs) were isolated from human peripheral blood
by Ficoll density gradient centrifugation, and then the cells were planted on the human
ﬁbronectin (FN) coated culture dishes. The cells were suspended in endothelial basal
medium (EBM-2) supplemented with EGM-2-MV-SingleQuots. EPCs were charac-
terized as adherent cells double positive for DiL-acLDL uptake and lectin binding by
direct ﬂuorescent staining under a laser scanning confocal microscope. After cultered
for 7 days, EPCs were randomized into 6 groups: control group, simvastatin group and
different concentrations of salvianolic acid groups (0.5, 2.5, 5,10mg/L). After different
periods of culturing (24h,48h,72h) the ability of cell proliferation was assayed with
MTT assay, counting adherent cells assayed the adhesion activity of EPCs, the NO
content was measured in the cell culture medium by nitrate reductase method to ﬁnd
the effect on cell secretion activity.
Results: Incubation of EPCs with Salvianolic acid increased the number of EPCs,
with a maximum at 5mg/L after 24 hours (P<0.01). In addition, Salvianolic acid
promotes EPCs proliferative, adhesive and NO secreting capacity.
Conclusions: Salvianolic acid can promote EPCs augmentation and enhance its
proliferation, adhension and NO secreting function. It is likely to be a new mechanism
of EPCs for therapy ischemic disease.
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Objectives: The purpose of this study was to investigate the role of small interference
RNA (siRNA) on expression of E637K-hERG (human ether-a-go-go-related gene)
mutant and whether it can be used to rescue the mutant’s dominant-negative sup-
pressive effects on hERG protein channel function.
Methods: Western blot was performed to select the most sensitive siRNs to target
E637K-hERG mutant knockdown. Confocal laser scanning microscope was per-
formed to monitor cellular localization of wild-type (WT) -hERGandE637K-hERG
with or without siRNA. Patch-clamp technique was used to assess the effect of siRNA
on the electrophysiologic characteristics of the rapidly activating delayed rectiﬁer K+
current IKr of the hERG protein channel.
Results: siRNA led to a signiﬁcant decrease in the level of E637K- hERGprotein but did
not affect the level of WT-hERG protein. WT-hERG localization in cells coexpressing
E637K-hERG mutant was restored to the membrane by siRNA. The siRNA-mediated
inhibition of E637K-hERG mutant restored the maximum current and tail current am-
plitudes. Furthermore, siRNA treatment rescued the kinetic properties of WT/E637K-
hERG protein channel to a level comparable to that of WT-hERG protein channel.
Conclusions: Our ﬁndings illustrated that siRNA can effectively inhibit E637K-
hERG protein expression and rescue the dominant- negative effect of this mutation by
restoring the kinetic properties of hERG protein channel. It has potential clinical
implications with regard to the possibility of using siRNA in the treatment of LQTS.
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